Holdings of Avidity Partners Management LP
39 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 84.9 % of the equity sleeve
Sector breakdown
- Health care 3.1 %
- Consumer staples 0.4 %
- Unattributed 96.5 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
The quoted currency of each line, as declared.
Country breakdown
- US 96.7 %
- IL 2.8 %
- DK 0.3 %
- FR 0.2 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|
| 1 | US | 36 | 462.7M $ | 96.66 % |
| 2 | IL | 1 | 13.6M $ | 2.83 % |
| 3 | DK | 1 | 1.3M $ | 0.28 % |
| 4 | FR | 1 | 1.1M $ | 0.23 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|
| 1 | Dianthus Therapeutics Inc | 2,104,184 | 176.6M $ | |
| 2 | CG oncology Inc | 1,288,948 | 87.2M $ | |
| 3 | Oruka Therapeutics Inc | 760,424 | 37.3M $ | |
| 4 | Perspective Therapeutics Inc | 6,049,999 | 25.2M $ | |
| 5 | JADE BIOSCIENCES INC | 1,400,708 | 19.7M $ | |
| 6 | Enliven Therapeutics Inc | 400,000 | 15.7M $ | |
| 7 | Teva Pharmaceutical Industries Ltd | 450,100 | 13.6M $ | |
| 8 | Context Therapeutics Inc | 4,998,267 | 13.1M $ | |
| 9 | Repligen Corp | 77,800 | 9.2M $ | |
| 10 | Palvella Therapeutics Inc | 70,000 | 8.7M $ | |
| 11 | Vir Biotechnology Inc | 950,000 | 8.5M $ | |
| 12 | Aktis Oncology Inc | 468,566 | 8.4M $ | |
| 13 | IMMUNIC INC | 6,699,411 | 7.4M $ | |
| 14 | Dexcom Inc | 90,000 | 5.7M $ | |
| 15 | Encompass Health Corp | 42,000 | 4.1M $ | |
| 16 | Boston Scientific Corp | 60,000 | 3.8M $ | |
| 17 | Tenax Therapeutics Inc | 215,934 | 3.5M $ | |
| 18 | Gilead Sciences Inc | 20,000 | 2.8M $ | |
| 19 | Phathom Pharmaceuticals Inc | 249,390 | 2.8M $ | |
| 20 | Karyopharm Therapeutics Inc | 463,741 | 2.6M $ | |
| 21 | Centene Corp | 70,000 | 2.3M $ | |
| 22 | SCYNEXIS INC | 2,081,660 | 1.9M $ | |
| 23 | Natera Inc | 9,000 | 1.8M $ | |
| 24 | Kenvue Inc | 100,000 | 1.7M $ | |
| 25 | Corvus Pharmaceuticals Inc | 115,000 | 1.7M $ | |
| 26 | Hims & Hers Health Inc | 75,000 | 1.6M $ | |
| 27 | Revolution Medicines Inc | 15,000 | 1.5M $ | |
| 28 | Structure Therapeutics Inc | 30,000 | 1.4M $ | |
| 29 | Genmab A/S | 50,000 | 1.3M $ | |
| 30 | Corcept Therapeutics Inc | 30,000 | 1.2M $ | |
| 31 | Tempus AI Inc | 25,000 | 1.1M $ | |
| 32 | Abivax SA | 10,000 | 1.1M $ | |
| 33 | UnitedHealth Group Inc | 3,800 | 1M $ | |
| 34 | Intellia Therapeutics Inc | 75,000 | 961.5K $ | |
| 35 | Peloton Interactive Inc | 200,000 | 858K $ | |
| 36 | Anteris Technologies Global Corp | 150,000 | 832.5K $ | |
| 37 | BridgeBio Oncology Therapeutics Inc | 43,853 | 392.5K $ | |
| 38 | ACADIA Pharmaceuticals Inc | 12,967 | 288.6K $ | |
| 39 | Trevi Therapeutics Inc | 6,660 | 79.5K $ | |